Yet, despite the fact that insulin glargine did not significantly enhance MG tumor development, many insulin glargine tumors also demonstrated enhanced Erk and Akt activity, which was hardly observed under control conditions. This evidence concerns the gene AKT1 and myasthenia gravis.